Botulism immune globulin intravenous (Human, California department of health services)

N/A

Report date: 2022/01/14 13:23:58

Base Information

Drug NameBotulism immune globulin intravenous (Human, California department of health services)
Drug Alias NameBotulism immune globulin intravenous (human)่‚‰ๆฏ’ๆ†่Œๅ…็–ซ็ƒ่›‹็™ฝHuman-derived botulinum antitoxinIV botulism immune globulinBotulinum toxin immune globulin +[9]ย 
ClassificationBiologics > Blood components
Mechanisms of ActionBotulinum toxin inhibitors
TargetsBotulinum toxin
Therapy Area/IndicationsBotulism
Global Approved IndicationsBotulism
Approved Indications in ChinaN/A
Original Approved Country/TerritoryUnited States
Original Approved Date2003/10/23
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaN/A
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesN/A
Active IndicationsBotulism
Inactive IndicationsN/A

Other Information

ATC CodeJ06AA04
Related LinksN/A